ANTIPODES PARTNERS Ltd Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001652442
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2023 · 69 positions · Total reported value $3.11B · Top-10 concentration 48.6% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 65.0% · 30 new · 58 cut · 16 exited
Active Share (vs S&P 500): 82.7% · vs QQQ: 84.2% — share of the book that differs from index weights (higher = more active) · ranking
In its Q3 2023 13F filing, ANTIPODES PARTNERS Ltd disclosed 69 equity positions with a combined reported value of $3.11B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 48.6% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.
The largest disclosed positions as of Q3 2023 were MRK ($236.76M), ORCL ($180.70M), BIDU ($175.19M). By sector, the heaviest allocations are Technology 25.2%, Industrials 15.1%.
Versus the prior quarter, ANTIPODES PARTNERS Ltd opened 30 new positions, trimmed 58 and fully exited 16, a turnover rate of 65.0% of positions.
The largest new positions opened in Q3 2023 were MRK ($236.76M), ORCL ($180.70M), BIDU ($175.19M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2023)
Fully Exited (vs previous quarter)
No tracked position was fully exited this quarter.
Insider Transactions (Form 4)
Latest ANTIPODES PARTNERS Ltd buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Antipodes Partners Ltd is a Sydney, Australia-based investment firm founded by Tim Carney and Chris Murphy, known for its contrarian global equity investment strategy.
Investment Approach
Contrarian deep value strategy focusing on undervalued companies with turnaround potential.
Asset Classes
Global equities with emphasis on US markets (as evidenced by SEC 13F filings).
Key People
Founded by Tim Carney and Chris Murphy, experienced value investors with long track records.
Firm Overview
Established in 2009, Sydney-based with $14.6B AUM (per SEC Form ADV).
Official disclosures available through SEC filings.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
2.27M | $236.76M | 7.61% | New | |
| 2 |
|
1.70M | $180.70M | 5.81% | New | |
| 3 |
|
1.32M | $175.19M | 5.63% | New | |
| 4 |
|
466.66K | $146.36M | 4.70% | New | |
| 5 |
|
1.95M | $145.84M | 4.69% | New | |
| 6 |
|
1.15M | $145.49M | 4.67% | New | |
| 7 |
|
636.77K | $135.15M | 4.34% | New | |
| 8 |
|
1.12M | $120.36M | 3.87% | New | |
| 9 |
|
7.49M | $114.22M | 3.67% | New | |
| 10 |
|
20.82M | $111.37M | 3.58% | New | |
| 11 |
|
5.75M | $110.80M | 3.56% | New | |
| 12 |
|
2.60M | $110.45M | 3.55% | New | |
| 13 |
|
529.46K | $110.01M | 3.54% | New | |
| 14 |
|
7.20M | $104.89M | 3.37% | New | |
| 15 |
|
1.21M | $103.88M | 3.34% | New | |
| 16 |
|
1.54M | $101.62M | 3.27% | New | |
| 17 |
|
326.87K | $99.35M | 3.19% | New | |
| 18 |
|
526.10K | $96.20M | 3.09% | New | |
| 19 |
|
710.39K | $67.16M | 2.16% | New | |
| 20 |
|
1.69M | $66.52M | 2.14% | New | |
| 21 |
|
1.14M | $58.39M | 1.88% | New | |
| 22 |
|
584.16K | $56.67M | 1.82% | New | |
| 23 |
|
16.27M | $49.64M | 1.59% | New | |
| 24 |
|
736.88K | $48.41M | 1.55% | New | |
| 25 |
|
695.84K | $47.37M | 1.52% | New | |
| 26 |
|
705.84K | $46.02M | 1.48% | New | |
| 27 |
|
5.10M | $44.20M | 1.42% | New | |
| 28 |
|
631.30K | $43.24M | 1.39% | New | |
| 29 |
|
464.11K | $40.77M | 1.31% | New | |
| 30 |
|
1.19M | $31.43M | 1.01% | New | |
| 31 |
|
174.72K | $29.17M | 0.94% | New | |
| 32 |
|
865.02K | $22.79M | 0.73% | New | |
| 33 |
|
111.83K | $19.46M | 0.62% | New | |
| 34 |
|
4.57M | $14.43M | 0.46% | New | |
| 35 |
|
248.55K | $13.87M | 0.45% | New | |
| 36 |
|
974.52K | $11.77M | 0.38% | New | |
| 37 |
|
107.52K | $11.69M | 0.38% | New | |
| 38 |
|
134.01K | $7.13M | 0.23% | New | |
| 39 |
|
85.45K | $6.88M | 0.22% | New | |
| 40 |
|
47.42K | $6.55M | 0.21% | New | |
| 41 |
|
169.32K | $6.27M | 0.20% | New | |
| 42 |
|
2.72M | $5.33M | 0.17% | New | |
| 43 |
|
88.53K | $3.11M | 0.10% | New | |
| 44 |
|
13.72K | $2.32M | 0.07% | New | |
| 45 |
|
8.66K | $545.00K | 0.02% | New | |
| 46 |
|
40.04K | $427.00K | 0.01% | New | |
| 47 |
|
40.57K | $291.00K | 0.01% | New | |
| 48 |
|
1.30K | $257.00K | 0.01% | New | |
| 49 |
|
27.91K | $203.00K | 0.01% | New | |
| 50 |
|
2.88K | $167.00K | 0.01% | New | |
FAQ
What did ANTIPODES PARTNERS Ltd buy in 2023-Q3?
In its 2023-Q3 13F filing, ANTIPODES PARTNERS Ltd reported 69 equity positions worth $3.11B in aggregate; its largest disclosed positions were MRK ($236.76M), ORCL ($180.70M), BIDU ($175.19M).
How large is ANTIPODES PARTNERS Ltd's portfolio?
ANTIPODES PARTNERS Ltd reported $3.11B of long equity holdings across 69 positions as of 2023-Q3. Top-10 holdings account for 48.6% of reported value.
What is ANTIPODES PARTNERS Ltd's investment style?
HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.